Full data from the primary analysis of the positive, single-arm Phase 2 PICCOLO trial, evaluating mirvetuximab soravtansine (ELAHERE®), for high folate receptor-alpha (FRα) expressing platinum-sensitive ovarian cancer (PSOC) (mini-oral presentation)…. Read More
Transfer of outreach services brings enhanced global resources to region, including expanded access to advanced testing, innovative digital tools for improved patient experience and achieves Ballad Health’s goal of continuing… Read More
MISSISSAUGA, ON – The Amgen Biotech Experience (ABE) is celebrating a milestone that speaks volumes—not just a number, but a clear message of growth and enthusiasm in the science community…. Read More
Vancouver, BC & NY – Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for autoimmune diseases, has received an award from Breakthrough T1D (formerly JDRF) to advance INT’s technology… Read More
B.C.’s health care organizations are driving evidence-based practice improvements and elevating patient care across the province. The Knowledge Translation (KT) Challenge is an annual program that has been run in collaboration with… Read More
